Dr. Bernard Tisserand and
Dr. Jonny L. Salyer have been named executive medical directors for respiratory disorders and metabolic disorders, respectively,
MDS Pharma Services.
"Pharmaceutical companies are pursuing clinical research programs to address these disorders, and we have made a strategic decision to become a leader in these key therapeutic arenas by establishing dedicated teams headed by experienced medical professionals," said MDS Pharma Services President David Spaight. "In the past 10 years, MDS Pharma Services has managed more than 150 clinical projects involving respiratory conditions and metabolic disorders. With expert project teams in Africa, Asia Pacific, Europe, Latin America and North America, we can offer our clients worldwide access to patients with these conditions."
Dr. Tisserand has held a number of senior positions in clinical operations and project management at MDS Pharma Services. In his earlier roles, he managed teams of project directors, project leaders and clinical research associates supporting studies in asthma, allergic rhinitis, COPD, CAP and other major therapeutic areas. He has been with the company for 18 years.
Dr. Salyer has 30 years of relevant experience in research, medicine and the contract research industry. Prior to joining the company, she worked for a leading provider of central lab services in Indianapolis, where she served as director of medical affairs since 2001, supporting Phase I-IV clinical research.
Magazine
